Fadhil, H.R. , Al-Jumaili, A.A. and Al-Ani, N.A. (2023) “Cost-effectiveness Analysis of Reference Infliximab (Remicade) Compared to its Biosimilar (Remsima) in Iraqi Patients with Rheumatoid Arthritis (Conference Paper )#”, Iraqi Journal of Pharmaceutical Sciences, 31(Suppl.), pp. 100–110. doi:10.31351/vol31issSuppl.pp100-110.